Company Name: Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. The company is engaged in the development of cancer treatments. The company’s focus is on its product candidate entinostat, a combination therapeutic for several cancers (initial focus is on tumors sensitive to immunotherapy).
Ticker Symbol: SNDX (NASDAQ)
Company Website: www.syndax.com
Headquarters: Waltham, Massachusetts